Home › Alopecia Areata › New York
Alopecia Areata clinical trials in New York
6 studies for Alopecia Areata are looking for participants at sites in New York.
Cities in New York
Dupilumab in the Treatment of Pediatric Alopecia Areata
- Icahn School of Medicine at Mount Sinai, New York
RecruitingPhase 2
Ages 6 to 17 · All sexes · Updated Sep 2, 2026 · NCT05866562A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
- Equity Medical /ID# 266680, New York
- Sadick Research Group LLC /ID# 266790, New York
RecruitingPhase 3
Ages 12 to 63 · All sexes · Updated Aug 3, 2026 · NCT06012240Regeneron AA Multicenter (Dupilumab)
- Icahn School of Medicine at Mount Sinai, New York
- UR Dermatology at College Town, Rochester
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 17, 2026 · NCT05551793A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
- Equity Medical, LLC, The Bronx
RecruitingPhase 3
Ages 6 to 14 · All sexes · Updated Apr 28, 2026 · NCT07029828Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome
- Icahn School of Medicine at Mount Sinai, New York
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Feb 2, 2026 · NCT07242638Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
- Vitality Clinical Trials, Woodbury
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Jan 28, 2026 · NCT07133308From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.